Wu S, Bafna V, Chang HY, Mischel PS. Extrachromosomal DNA: an emerging hallmark in human cancer. Annu Rev Pathol Mech Dis. 2022;17:854744578.

Article  Google Scholar 

Liao Z, Jiang W, Ye L, Li T, Yu X, Liu L. Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression. Biochim Biophys Acta BBA Rev Cancer. 2020;1874:188392.

Article  CAS  Google Scholar 

Bailey C, Shoura MJ, Mischel PS, Swanton C. Extrachromosomal DNA-relieving heredity constraints, accelerating tumour evolution. Ann Oncol. 2020;31:884–93.

Article  CAS  PubMed  Google Scholar 

Helmsauer K, Valieva ME, Ali S, Chamorro González R, Schöpflin R, Röefzaad C, et al. Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma. Nat Commun. 2020;11:5823.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morton AR, Dogan-Artun N, Faber ZJ, MacLeod G, Bartels CF, Piazza MS, et al. Functional enhancers shape extrachromosomal oncogene amplifications. Cell. 2019;179:1330–1341.e13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu S, Turner KM, Nguyen N, Raviram R, Erb M, Santini J, et al. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature. 2019;575:699–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hung KL, Mischel PS, Chang HY. Gene regulation on extrachromosomal DNA. Nat Struct Mol Biol. 2022;29:736–44.

Article  CAS  PubMed  Google Scholar 

Lubs HA, Salmon JH. The chromosomal complement of human solid tumors: II. Karyotypes of glial tumors. J Neurosurg. 1965;22:160–8.

Article  PubMed  Google Scholar 

Kim H. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat Genet. 2020;52:20.

Article  Google Scholar 

Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, et al. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell. 1983;35:359–67.

Article  CAS  PubMed  Google Scholar 

Hoff DDV, Needham-VanDevanter DR, Yucel J, Windle BE, Wahl GM. Amplified human MYC oncogenes localized to replicating submicroscopic circular DNA molecules. Proc Natl Acad Sci USA. 1988;85:4804–8.

Article  Google Scholar 

Nathanson DA, Gini B, Mottahedeh J, Visnyei K, Koga T, Gomez G, et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. 2014;343:72–76.

Article  CAS  PubMed  Google Scholar 

Ain Q, Schmeer C, Wengerodt D, Witte OW, Kretz A. Extrachromosomal circular DNA: current knowledge and implications for CNS aging and neurodegeneration. Int J Mol Sci. 2020;21:2477.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deshpande V, Luebeck J, Nguyen N-PD, Bakhtiari M, Turner KM, Schwab R, et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat Commun. 2019;10:392.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulsen T, Kumar P, Koseoglu MM, Dutta A. Discoveries of extrachromosomal circles of DNA in normal and tumor cells. Trends Genet. 2018;34:270–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar P, Kiran S, Saha S, Su Z, Paulsen T, Chatrath A, et al. ATAC-seq identifies thousands of extrachromosomal circular DNA in cancer and cell lines. Sci Adv. 2020;6:eaba2489.

Article  PubMed  PubMed Central  Google Scholar 

Yan F, Powell DR, Curtis DJ, Wong NC. From reads to insight: a Hitchhiker’s guide to ATAC-seq data analysis. Genome Biol. 2020;21:22.

Article  PubMed  PubMed Central  Google Scholar 

Storlazzi CT, Lonoce A, Guastadisegni MC, Trombetta D, D’Addabbo P, Daniele G, et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 2010;20:1198–206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C-Z, Spektor A, Cornils H, Francis JM, Jackson EK, Liu S, et al. Chromothripsis from DNA damage in micronuclei. Nature. 2015;522:179–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leibowitz ML, Zhang C-Z, Pellman D. Chromothripsis: a new mechanism for rapid karyotype evolution. Annu Rev Genet. 2015;49:183–211.

Article  CAS  PubMed  Google Scholar 

Ly P, Brunner SF, Shoshani O, Kim DH, Lan W, Pyntikova T, et al. Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements. Nat Genet. 2019;51:705–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–10.

Turner KM. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017;543:122–5.

Wei J, Wu C, Meng H, Li M, Niu W, Zhan Y, et al. The biogenesis and roles of extrachromosomal oncogene involved in carcinogenesis and evolution. Am J Cancer Res. 2020;10:3532.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Prim. 2021;7:3.

Article  PubMed  Google Scholar 

Nau MM, Carney DN, Battey J, Johnson B, Little C, Gazdar A, et al. Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer. In: Potter M, Melchers F, Weigert M, editors. Oncogenes in B-cell neoplasia. Berlin, Heidelberg: Springer Berlin Heidelberg; 1984. p. 172–5.

Kim D-W, Wu N, Kim Y-C, Cheng PF, Basom R, Kim D, et al. Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer. Genes Dev. 2016;30:1289–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mollaoglu G, Guthrie MR, Böhm S, Brägelmann J, Can I, Ballieu PM, et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition. Cancer Cell. 2017;31:270–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Böttger F, Semenova EA, Song J-Y, Ferone G, van der Vliet J, Cozijnsen M, et al. Tumor heterogeneity underlies differential cisplatin sensitivity in mouse models of small-cell lung cancer. Cell Rep. 2019;27:3345–3358.e4.

Article  PubMed  PubMed Central  Google Scholar 

Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19:289–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

George J, Lim JS, Jang SJ, Cun Y, Ozretić L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell. 2021;39:346–360.e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, et al. Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study. J Pathol. 2022;257:674–86.

Owonikoko TK, Niu H, Nackaerts K, Csoszi T, Ostoros G, Mark Z, et al. Randomized phase II study of paclitaxel plus alisertib versus paclitaxel plus placebo as second-line therapy for SCLC: primary and correlative biomarker analyses. J Thorac Oncol. 2020;15:274–87.

Article  CAS  PubMed  Google Scholar 

Dauch D, Rudalska R, Cossa G, Nault J-C, Kang T-W, Wuestefeld T, et al. A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer. Nat Med. 2016;22:744–53.

Article  CAS  PubMed  Google Scholar 

Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012;41:D955–D961.

Article  PubMed  PubMed Central  Google Scholar 

Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12:109–16.

Article  CAS  PubMed  Google Scholar